Corporate Banner
Satellite Banner
Automation & Microfluidics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Stratophase Successfully Completes Bio-Detection Project

Published: Wednesday, June 22, 2011
Last Updated: Wednesday, June 22, 2011
Bookmark and Share
Portable optical microchip technology accurately detects Foot and Mouth Disease in laboratory tests.

Stratophase, has announced the successful completion of the Portable Direct Immunoassay Diagnosis Devices for Animals and Humans (PDIDDAH) project.

Using Stratophase’s proprietary optical microchip technology, the goal of the proof-of-principle study was to assess the feasibility of using a self-contained, portable detection unit to accurately identify the presence of Foot and Mouth Disease (FMD).

The £1 million project, co-funded by the UK government-sponsored Technology Strategy Board, was performed in collaboration with the Institute of Biotechnology (University of Cambridge), Bristol Industrial and Research Associates Limited and the Chelsea Technologies Group.

When testing the prototype in a laboratory environment, the unit was able to detect FMD quickly, easily and with a high degree of accuracy. If further developed, such a device would allow veterinary professionals, inspectors and farmers to make rapid, informed decisions at the site of infection during disease outbreaks, avoiding the need to cull of healthy livestock.

To address this need, Stratophase has developed a transportable FMD detection unit utilizing the company’s proprietary optical microchip technology, which measures changes in refractive index (RI) at the surface of an optical chip.

During analysis, the sample is mixed with a liquid and pumped across the chip surface, where any FMD viral particles present bind to specific receptor molecules, altering the local RI and leading to positive detection.

The chips themselves are incorporated into low cost, disposable cartridges, which are inserted into the detection unit during testing. The research carried out as part of the PDIDDAH project has successfully shown that the platform has the potential to provide a robust, rapid, accurate, easy-to-use solution for the on-site detection of FMD.

On completion of the project, Richard Williams, Stratophase’s chief executive, said, “We are delighted with the results of the PDIDDAH collaboration and believe it provides the perfect basis for further developing our bio-detection technology. As well as a clear application in veterinary diagnostics, our optical microchips can be configured to detect a whole range of biological agents, making them ideal for on-site testing in environments as diverse as battlefields, hospitals and farms.”

The success of the project has showcased what can be achieved using Stratophase’s technology, and the company expects to commercialize its portable detection solution for veterinary diagnostics in the future through collaboration with strategic partners already active in the field.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Stratophase Doubles Manufacturing Capacity and Increases Applications Development
Company moves to larger facility to easily respond to different application requirements for implementing and testing new optical measurement techniques.
Friday, July 16, 2010
Stratophase Heads £1.2m Project to Develop Real-Time High Value Liquid Monitoring Systems
Project will utilize Stratophase’s advanced SpectroSens optical microchip technology to increase yield and minimize waste.
Wednesday, March 10, 2010
Stratophase develops new SpectroSens Insertion Probe for real-time Bioproduction Monitoring
Collaboration with CPI leads to improved bioprocess efficiency
Wednesday, November 11, 2009
Scientific News
Releasing Cancer Cells for Better Analysis
A new device developed at the University of Michigan could provide a non-invasive way to monitor the progress of an advanced cancer treatment.
Releasing Cancer Cells for Better Analysis
A new device developed at the University of Michigan could provide a non-invasive way to monitor the progress of an advanced cancer treatment.
Lab-on-a-Chip for Detecting Glucose
By integrating microfluidic chips with fiber optic biosensors, researchers in China are creating ultrasensitive lab-on-a-chip devices to detect glucose levels.
Soy Shows Promise as Natural Anti-Microbial Agent
Soy isoflavones and peptides may inhibit the growth of microbial pathogens that cause food-borne illnesses, according to a new study from University of Guelph researchers.
Soy Shows Promise as Natural Anti-Microbial Agent
Researchers from University of Guelph show that soy isoflavones and peptides could be used to reduce microbial contamination of food.
Parsortix Demonstrates Benefits Over Marker-Based Systems
Research published online in the International Journal of Cancer, shows the ParsortixTM System efficiently captures and harvests intact, viable circulating tumour cells (CTCs), including EpCAM-negative CTCs, to allow for broader downstream CTC analysis.
Experimental Therapy For Brain Cancer Could Prevent Drug Resistance
Information from penny-sized microfluidic chips allowed researchers to anticipate resistance to cancer treatment.
3D Printing of Lego Fluidics
Study shows how 3D printing can open up microfluidic technology to a wider audience.
New Method to Preserve Device to Monitor HIV Treatment
Inspired by pregnancy tests, scientists have developed a method to store microfluidic devices for months without refrigeration, giving developing countries an inexpensive and reliable way to treat patients.
Migration Creates Cancer Cell Vulnerabilities
Scientists found that migration can damage cancer cells’ nuclei and DNA, requiring repairs for their survival. The results may open new avenues for targeting metastatic cancer.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!